Reinnervate to present and exhibit at the American Society for Cell Biology annual conference 2011

Reinnervate, the expert in making routine 3D cell culture a reality, has announced that the company will exhibit and present at this year’s American Society for Cell Biology (ASCB) annual conference (Denver, USA, 3 – 7th December 2011). Reinnervate’s Chief Scientific Officer, Professor Stefan Przyborski, will deliver a case study presentation at 18.15 on Sunday 4th December entitled ‘Enabling Routine 3D Cell Culture for Disease Modelling, Toxicity Screening and Safety Testing’. Seats are available on a first come, first served basis, and can be booked online via the Reinnervate website. The talk will discuss the use of alvetex®, Reinnervate’s innovative polystyrene scaffold which allows cells to grow and form complex 3D structures, thereby mimicking cellular growth in vivo. In addition, the company will be exhibiting at booth 153, where Reinnervate experts will be on hand to discuss how the company’s range of novel 3D cell culture products can meet your research needs.

As places for Professor Przyborski’s talk are limited, attendees are advised to book their seat as soon as possible using the company’s simple online registration form.

About reinnervate

Reinnervate is an innovative life sciences company dedicated to making routine 3D cell culture a reality for researchers in academia and in the pharmaceutical and related industries.

Reinnervate’s core technology is alvetex®, a unique and proprietary scaffold that enables routine 3D cell culture in the laboratory. Alvetex® provides a nanoscale environment that supports genuine homogeneous 3D cell growth. Cells grown using alvetex form complex 3D tissue cultures which more closely mimic normal in-vivo cell growth and the formation of tissues in the body than conventional techniques. The use of alvetex-derived 3D cell cultures can provide researchers with greater insight into how cells behave in the body in response to external factors (such as drug candidates) than is currently possible with existing 2D or other emerging 3D cell culture technologies.

Reinnervate has generated significant data, which have been published extensively in peer-reviewed publications, exemplifying the use of alvetex in a large number of cell types and applications. Alvetex® has been launched globally in several formats: a 12-well culture plate, 6-well and 12-well inserts and a deep well petri dish.

Reinnervate continues to develop its technology for use in the 3D cell culture. During 2012 Reinnervate will deliver further innovative products to help researchers improve the growth and function of their cultured cells

Reinnervate was founded in 2002 based on the pioneering research of Professor Stefan Przyborski and his lab at Durham University, UK, and is funded by NorthStar Equity Investors (NSEI), management and private investors.

www.reinnervate.com
www.reinnervate.com/company-video

Alto Marketing
Office 3, Universal Marina
Crableck Lane
Sarisbury Green
Southampton
SO31 7AL

This release was published on openPR.